drugset / Trial / NCT05047692
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
Non-randomizedSequentialOpen-labelPrevention
Summary
This is a Phase 1 clinical trial to assess the safety and immunogenicity of AdCLD-CoV19-1 in healthy adults.
Timeline
- Start
- 2021-09-09
- Primary completion
- 2022-12-02
- Completion
- 2023-06-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AdCLD-CoV19-1 | Vaccine | 5e+10 unknown | Intramuscular |
| Subject | AdCLD-CoV19-1 | Vaccine | 1e+11 unknown | Intramuscular |